Advertisement

Prednisone Tablets

[23 March 2015]

Products Affected - Description

Prednisone Tablets, West-Ward
5 mg tablets, 100 count (NDC 00143-1475-01)
5 mg tablets, 1000 count (NDC 00143-1475-10)
10 mg tablets, 100 count (NDC 00143-1473-01)

Reason for the Shortage

  • Cadista states the shortage was due to a raw materials shortage.
  • Perrigo discontinued prednisone tablets in 2013.
  • Qualitest will not provide shortage information for any of their products because they consider the information to be proprietary. 
  • West-Ward states the reason for the shortage is manufacturing delays.

Available Products

Prednisone Tablets, Cadista
1 mg tablets, 100 count (NDC 59746-0171-06)
1 mg tablets, 1000 count (NDC 59746-0171-10)
5 mg tablets, 100 count (NDC 59746-0172-06)
5 mg tablets, 1000 count (NDC 59746-0172-10)
10 mg tablets, 1000 count (NDC 59746-0173-10)
10 mg tablets, 100 count (NDC 59746-0173-06)
20 mg tablets, 100 count (NDC 59746-0175-06)
20 mg tablets, 500 count (NDC 59746-0175-09)
 
Prednisone Tablets, Roxane
1 mg tablets, 100 count (NDC 00054-4741-25)
1 mg tablets, 1000 count (NDC 00054-4741-31)
1 mg tablets, 100 count unit dose (NDC 00054-8739-25)
2.5 mg tablets, 100 count (NDC 00054-4742-25)
2.5 mg tablets, 100 count unit dose (NDC 00054-8740-25)
5 mg tablets, 1000 count (NDC 00054-4728-31)
5 mg tablets, 100 count (NDC 00054-4728-25)
5 mg tablets, 100 count unit dose (NDC 00054-8724-25)
10 mg tablets, 100 count (NDC 00054-0017-25)
10 mg tablets, 500 count (NDC 00054-0017-29)
10 mg tablets, 100 count unit dose (NDC 00054-0017-20)
20 mg tablets, 100 count (NDC 00054-0018-25)
20 mg tablets, 500 count (NDC 00054-0018-29)
20 mg tablets, 100 count unit dose (NDC 00054-0018-20)
50 mg tablets, 100 count (NDC 00054-0019-25)
50 mg tablets, 100 count unit dose (NDC 00054-0019-20)
 
Prednisone Tablets, Actavis (formerly Watson)
5 mg tablets, 100 count (NDC 00591-5052-01)
5 mg tablets, 1000 count (NDC 00591-5052-10)
10 mg tablets, 100 count (NDC 00591-5442-01)
10 mg tablets, 500 count (NDC 00591-5442-05)
10 mg tablets, 1000 count (NDC 00591-5442-10)
20 mg tablets, 100 count (NDC 00591-5443-01)
20 mg tablets, 500 count (NDC 00591-5443-05)
20 mg tablets, 1000 count (NDC 00591-5443-10)

Prednisone Tablets, West-Ward
5 mg tablets, 100 count (NDC 00143-9740-01)
5 mg tablets, 1000 count (NDC 00143-9740-10)
10 mg tablets, 100 count (NDC 00143-9739-01)
10 mg tablets, 1000 count (NDC 00143-9739-10)
20 mg tablets, 100 count (NDC 00143-9738-01)
20 mg tablets, 500 count (NDC 00143-9738-05)
20 mg tablets, 1000 count (NDC 00143-9738-10)

Estimated Resupply Dates

West-Ward has prednisone tablets 5 mg 100 count (NDC 00143-1475-01), 5 mg 1000 count (NDC 00143-1475-10), and 10 mg 100 count (NDC 00143-1473-01) presentations on back order and the company cannot estimate a release date.

Related Shortages

Updated

March 2 and 23, January 14 and 30, 2015; December 3, 12 and 22, October 23, September 24, July 17, May 15 and 30, April 3, March 14, February 5, January 3 and 22, 2014; November 27, October 9 and 23, September 26, August 29, July 16, May 1, April 5, March 15, February 7, January 3, 2013; December 7, November 5 and 16, October 16, September 7 and 26, August 3 and 7, July 10, June 14, 2012.  University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement